Adding stem cells to common bypass surgery may reduce heart failure

Apr 05, 2011

In a new research study under way at the Methodist DeBakey Heart & Vascular Center, surgeons are adding a patient’s own stem cells to the heart during cardiac bypass surgery. The goal of this research study is to determine whether the stem cell infusion will generate new blood vessels and improve heart function more than what is seen through bypass surgery alone.

"The injection of stem cells may improve the effectiveness of the bypass," said Dr. Brian Bruckner, cardiac surgeon and principle investigator on the research study. "We perform a bypass to reroute blood flow around blockages in the coronary arteries. The injection of stem cells might enhance the bypass surgery by causing the formation of new blood vessels at the site of injection."

In this study, stem cells are harvested from a subject’s own in the operating room while the research subject is under anesthesia. After the bone marrow cells are harvested, the surgeon then begins the bypass procedure. These cells are simultaneously processed to separate stem cells from bone marrow. After performing the bypass, the surgeon then injects the stem cells into the patient’s , and the procedure is complete.

The Methodist DeBakey Heart & Vascular Center is one of only three centers in the country to have this study available.

A potential benefit for study subjects is that the stem cells can be delivered during the bypass surgery, rather than needing an additional procedure," said Dr. Kevin Lisman, cardiologist at the Methodist DeBakey Heart & Vascular Center and co-investigator in the study. "To be considered for this trial, patients must have an existing need for heart and must have an ejection fraction of 40 percent or less. Up to 42 patients will be enrolled in this randomized study nationwide."

The research team cannot guarantee individual benefits from participating in the study.

The technology that processes the was developed by Harvest Technologies and it sorts the cells quickly, enabling the procedure to be interoperative, rather than having the patient come in days before surgery for the bone marrow aspiration.

Explore further: Steadily rising increases in mitochondrial DNA mutations cause abrupt shifts in disease

Provided by Methodist Hospital System

3 /5 (1 vote)
add to favorites email to friend print save as pdf

Related Stories

Stem cells to be injected into the heart

Aug 26, 2005

The University of Pittsburgh Medical Center will begin a clinical trial to determine the feasibility of injecting a patient's own stem cells into the heart.

Stem cells to repair damaged heart muscle

Jun 22, 2007

In the first trial of its kind in the world, 60 patients who have recently suffered a major heart attack will be injected with selected stem cells from their own bone marrow during routine coronary bypass surgery.

How can you heal a broken heart?

Apr 12, 2010

Some patients with heart muscles seriously affected by coronary heart disease may soon be able to benefit from an innovative treatment. Researchers at the Research Centre of the Centre hospitalier de l'Université de ...

Recommended for you

Cause of ageing remains elusive

10 hours ago

A report by Chinese researchers in the journal Nature a few months ago was a small sensation: they appeared to have found the cause for why organisms age. An international team of scientists, headed by the ...

Newly discovered bacterial defence mechanism in the lungs

12 hours ago

A new study from Karolinska Institutet presents a previously unknown immunological mechanism that protects us against bacterial infections in the lungs. The study is being published in the American Journal of Respiratory an ...

User comments : 0